Followers | 134 |
Posts | 7040 |
Boards Moderated | 0 |
Alias Born | 02/09/2012 |
![](https://investorshub.advfn.com/uicon/323933.png?cb=1618788139)
Saturday, June 19, 2021 2:13:22 PM
"Cover up!" assertion should be given a rest until at least around the second week of July.
IS an understatement...and ALSO an obvious misrepresentation of the IPIX's RP as to when DATA MAY BE RELEASED (PER FDA PROTOCOL):
https://www.ipharminc.com/press-release/2021/6/3/innovation-pharma-completes-enrollment-in-phase-2-clinical-trial-for-covid-19
"Complete trial enrollment comprised 120 dosed patients recruited across multiple sites. Final data collection for [color=red]the last patient enrolled in the study is expected to occur in early August (Study Day 60), which will then be followed by the process of unblinding study data and the reporting of topline study results."
The data cannot be released...no less published, for 60 days after the last patient has completed the Brilacidin regime. (beginning of August)...at which time data will be released for analysis...analysis takes time...then comes the reporting of data and analysis)
Left out the comments was reference to the TOTAL FDA WAITING PERIOD OF 60 Days (inclusive of the 29-day patient follow-up):
"...How could they know the "Time to sustained recovery through Day 29" when for some patients Day 29 has yet to occur?"
Surely an oversight? LOL...
THIS IS A NON-ISSUE...and Data release timing is at this point a Strawman argument ... which has no basis for raising until August and then only after a reasonable time for analysis has passed, at which time analysis and data would be released.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM